General Wellbeing

General wellbeing covers the everyday health conditions that most UK adults will meet at some point — migraine, insomnia, high cholesterol, smoking, and the smaller things like jet lag and cystitis that quietly disrupt life. This guide walks through what the NHS and NICE pathways typically look like for each, how treatment decisions are made, and where a UK online pharmacy such as Farmeci can support you alongside your GP.

What we mean by general wellbeing

General wellbeing is a broad category, but the conditions we cover here share a few characteristics. They are common, they respond to a mix of lifestyle change and, where appropriate, medication, and most people can be looked after in primary care rather than by a specialist. Migraine, insomnia, raised cholesterol and tobacco use are among the most frequent reasons UK adults see their GP or pharmacist, and each has a clearly mapped treatment ladder. Smaller everyday issues — jet lag on a long-haul return, an uncomplicated urinary tract infection (UTI) in an otherwise well woman — sit alongside them, often managed by the community pharmacy under the NHS Pharmacy First scheme.

These conditions overlap in more ways than people realise. Poor sleep worsens migraine frequency, migraine drives caffeine and painkiller use that in turn worsens sleep, smoking raises cardiovascular risk that already sits on top of high cholesterol, and untreated migraine drives significant work absence. Treating them one by one rarely delivers the full benefit — a joined-up approach with a clinician is usually what changes the picture.

Who is affected and when to consider treatment

Migraine affects around one in seven adults in the UK, is roughly three times more common in women than men, and typically starts in adolescence or early adulthood. Consideration of preventive treatment usually enters the conversation when a reader has four or more migraine days a month, when acute medicines are being used more than twice a week (a risk factor for medication-overuse headache), or when attacks are severe enough to reliably stop work.

Insomnia — difficulty falling asleep, staying asleep, or non-restorative sleep with daytime impact — affects roughly a third of UK adults intermittently and around ten per cent chronically. Treatment is worth considering when sleep disturbance has been present for at least three nights a week for three months, or when it is materially affecting mood, safety or daytime function. High cholesterol rarely causes symptoms of its own, which is why it is picked up on NHS Health Checks or opportunistic blood tests; treatment decisions rest on the reader's overall ten-year cardiovascular risk, calculated with the QRISK score, rather than the cholesterol number alone. Smoking cessation should be considered by any current smoker, at any age — the health gains begin within weeks.

The UK medical pathway

For migraine, the UK pathway starts with a headache diary, acute treatment optimisation, and lifestyle review (sleep, hydration, caffeine, meal timing, trigger identification). Where preventive treatment is needed, GPs commonly start with propranolol, amitriptyline or topiramate, moving to specialist headache services for CGRP monoclonal antibodies where standard options fail. Our patient guide on migraine treatment vs prevention explained walks through this in more detail.

For insomnia, NICE and the National Institute for Health and Care Excellence position cognitive behavioural therapy for insomnia (CBT-I) as first-line — not sleeping tablets. CBT-I can be accessed via NHS talking therapies, self-referral in most areas, or digital programmes such as Sleepio (available on the NHS in some regions). Short-term hypnotic medication (a Z-drug such as zopiclone, or occasionally a low-dose sedating antihistamine) may be considered for short bursts, but is not intended for ongoing nightly use. Melatonin is licensed in the UK for short-term use in adults over 55 and for specific paediatric indications. Our overview of insomnia and when to seek clinical help covers the assessment process.

For high cholesterol, the NHS uses the QRISK3 calculator to estimate ten-year cardiovascular risk. Statin therapy — usually atorvastatin — is offered where risk is 10 per cent or higher, alongside dietary review and physical activity advice. Familial hypercholesterolaemia (very high inherited cholesterol) follows a separate specialist pathway. For smoking cessation, the current NHS pathway typically starts with a Stop Smoking Service (free in most areas), nicotine replacement therapy (patches plus a short-acting form), varenicline where available, or nicotine-containing vapes as a harm-reduction tool.

Common treatment categories

Migraine — acute and preventive

Acute migraine treatment usually starts with a soluble non-steroidal anti-inflammatory (such as ibuprofen or naproxen) or a triptan such as sumatriptan, taken as early in the attack as possible. Anti-emetics like prochlorperazine can help when nausea limits absorption. Preventive treatment is considered where attacks are frequent or disabling; propranolol, amitriptyline, topiramate and candesartan are common first-line options. Medication-overuse headache is a real risk when acute medicines are used more than 10-15 days a month, and clinicians will actively look for this pattern.

Insomnia — CBT-I first, medicines with care

CBT-I is a structured, evidence-based programme covering sleep restriction, stimulus control, cognitive work on unhelpful sleep beliefs, and relaxation. It typically runs for four to eight sessions and can be delivered face-to-face or digitally. Where medication is considered, short courses of zopiclone or zolpidem may be used for acute insomnia; melatonin is licensed for short-term use in older adults. Long-term nightly hypnotics are not recommended because tolerance and rebound insomnia are common.

High cholesterol — statins and lifestyle

Statins reduce LDL cholesterol and lower cardiovascular event risk in eligible adults. Atorvastatin 20 mg is the usual NHS starting dose for primary prevention, with escalation guided by response and tolerability. Muscle aches are a commonly reported side effect but true statin-related myopathy is uncommon; your clinician will advise on how to distinguish the two. Lifestyle — reducing saturated fat intake, increasing oily fish, physical activity, and weight where relevant — remains part of every treatment plan, not an alternative to medication when risk is high.

Smoking cessation — combination therapy works best

The evidence consistently shows that combining a long-acting nicotine replacement (a 24-hour patch) with a short-acting form (gum, lozenge, spray or inhalator) roughly doubles quit success compared with a single product. Varenicline, where available, is another option and is offered through NHS Stop Smoking Services. Nicotine-containing vapes are recommended by the NHS as a harm-reduction quitting aid for adults who smoke, though they are not intended for lifelong use.

Everyday wellbeing basics

Short-haul jet lag usually settles within a couple of days with good sleep hygiene, daylight exposure at the destination, and hydration. Melatonin is sometimes considered for eastward long-haul travel under clinician guidance. Uncomplicated cystitis in women can often be managed via the NHS Pharmacy First scheme in England, which allows pharmacists to supply antibiotics for suitable cases without a GP appointment. Related respiratory and allergy topics — hay fever, sinusitis, asthma control — are covered in our allergies and respiratory hub.

What to expect from treatment

Timelines vary. Acute migraine treatment should ideally cut an attack short within two hours; preventive medicines are typically judged over a three-month trial, because full benefit is rarely seen in the first month. CBT-I usually shows meaningful improvement in sleep quality by weeks four to six. Statins reduce LDL cholesterol within a few weeks, with an NHS review usually at three months to check response and side effects. Smoking cessation is often a multi-attempt journey — most successful quitters made several attempts first, which is expected rather than a failure.

Side effects are usually manageable but worth flagging early: propranolol can cause fatigue and cold hands; amitriptyline can cause dry mouth and morning grogginess; topiramate can affect concentration and appetite; zopiclone can leave a bitter taste and next-day drowsiness; statins can cause muscle aches; nicotine replacement can cause vivid dreams or skin irritation. Your clinician will help weigh benefits against side effects for your specific situation.

When to seek urgent review

Some symptoms warrant same-day or emergency review rather than a routine appointment. For headache: a sudden thunderclap onset, a first severe headache after age 50, headache with fever and neck stiffness, headache with new neurological symptoms (weakness, speech disturbance, visual loss), or a headache that is progressively worsening over days. For sleep: severe daytime sleepiness with witnessed apnoeas may indicate obstructive sleep apnoea. For cardiovascular: chest pain, breathlessness or collapse are 999 calls, not GP appointments. For UTIs: high fever, loin pain, vomiting or confusion suggest possible upper urinary tract infection and need urgent review. The NHS.uk symptom checker and British National Formulary are useful references between appointments.

How Farmeci fits in

Farmeci is a UK GPhC-registered online pharmacy. This category exists to help you understand the UK pathway for common wellbeing conditions before you speak with a clinician, and to sit alongside — not replace — your GP relationship. For conditions such as smoking cessation, short courses of insomnia support, or ongoing repeat medicines, our free clinician-led consultation route can help you decide whether an online supply is appropriate for your circumstances. Where the clinical picture is complex, or a red-flag symptom appears, the right answer is always a face-to-face assessment.